Name: Silo Pharma, Inc. (SILO) Financial Statements
Creator: FinSpry

Silo Pharma Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Silo Pharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.07	0.07	0.07	0.07	0.00
Cost of Revenue	0.01	0.01	0.01	0.01	0.00
Gross Profit	0.07	0.07	0.07	0.07	0.00
Operating Expenses
Research & Development	2.37	0.85	1.29	0.69	0.03
Selling, General & Administrative	2.40	3.08	2.43	2.27	2.01
Operating Expenses	4.77	3.92	3.71	2.96	2.04
Operating Income	-4.71	-3.86	-3.65	-2.89	-2.04
Other Income/Expense
Interest Income	0.33	0.40	0.07	0.00	0.01
Interest Expense	-0.01	0.00	0.00	0.00	-0.27
Other Income/Expense	0.31	-0.17	-0.33	7.08	0.00
Income
Income Before Tax	-4.39	-3.63	-3.91	4.18	-2.67
Income Tax Expense	0.00	0.00	0.00	0.02	0.00
Net Income	-4.39	-3.70	-3.91	3.90	-3.04
Net Income - Continuous Operations	-4.39	-3.63	-3.91	4.16	0.00
Net Income - Discontinued Operations	0.00	-0.07	0.00	-0.25	0.00
EBITDA	-4.70	-3.63	-3.91	4.19	0.00
EBIT	-4.71	-3.63	-3.65	-2.89	-2.04
Depreciation & Amortization	0.01	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-2.00	1.00	-2.00
Diluted EPS	-1.00	-1.00	-2.00	1.00	-3.00
Basic Shares Outstanding	3.68	3.08	2.28	1.90	1.32
Diluted Shares Outstanding	3.68	3.08	2.28	1.92	1.32